madeometer

Made O'Meter

Discover where a brand or product originates

Repatha 140 mg injection

Owner:Amgen Inc. (USA)
OriginUSA
Manufactured:Multiple countries

Repatha (evolocumab) is a prescription biological medication used to reduce low-density lipoprotein (LDL) cholesterol. It was developed by Amgen, a pioneer in the biotechnology industry. The product shown is a pre-filled SureClick autoinjector containing 140 mg of the solution.

Manufacturing of biological products like Repatha is complex and typically involves multiple global sites across the United States, Ireland, and Puerto Rico, where Amgen maintains significant biotechnology manufacturing facilities. Ownership of the brand remains with Amgen Inc., an American multinational company that is one of the world's largest independent biotechnology firms. In Germany and other European markets, it is distributed through Amgen's local subsidiaries.

Made O'Meter uses AI-powered analysis to estimate production origins. Results are not always 100% accurate.

2025 i7even ApS Copenhagen Denmark - All rights reserved. Concepts and methods used in this app may not be reproduced without permission